Results 221 to 230 of about 13,693,576 (308)
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons +31 more
wiley +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers
ABSTRACT Objective Epidemiologic studies have reported inconsistent altered cancer risk in individuals with multiple sclerosis (MS). Factors such as immune dysregulation, comorbidities, and disease‐modifying therapies may contribute to this variability.
Asli Buyukkurt +5 more
wiley +1 more source
Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Uncertainty measure in evidence theory
Science China Information Sciences, 2020Yong Deng
semanticscholar +3 more sources
Quantum X-entropy in generalized quantum evidence theory
Information Sciences, 2023In this paper, a new quantum model of generalized quantum evidence theory is proposed. Besides, a new quantum X-entropy is proposed to measure the uncertainty in generalized quantum evidence theory.
Fuyuan Xiao
semanticscholar +1 more source
IEEE Transactions on Systems, Man, and Cybernetics: Systems, 2023
Evidence theory provides an effective representation and handling framework for uncertain information. However, the quantification for the uncertainty of mass function in this theory is still an unsolved problem.
Yebi Cui, Xinyang Deng
semanticscholar +1 more source
Evidence theory provides an effective representation and handling framework for uncertain information. However, the quantification for the uncertainty of mass function in this theory is still an unsolved problem.
Yebi Cui, Xinyang Deng
semanticscholar +1 more source
Information Sciences, 2022
Dempster-Shafer evidence theory, as an extension of Probability theory, is widely used in the field of information fusion due to it satisfies weaker conditions than probability theory in dealing with uncertain information.
Lipeng Pan, Yong Deng
semanticscholar +1 more source
Dempster-Shafer evidence theory, as an extension of Probability theory, is widely used in the field of information fusion due to it satisfies weaker conditions than probability theory in dealing with uncertain information.
Lipeng Pan, Yong Deng
semanticscholar +1 more source

